Clinical Trial Detail

NCT ID NCT02559024
Title Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Providence Health & Services
Indications

colorectal cancer

Therapies

MEDI6469

Age Groups: adult

No variant requirements are available.